Item List

Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.

"Expansion of our Board of Directors is particularly timely as we approach the beta release in early 2023 and commercial launch in the summer of 2023 of Pyxis™, our next-generation machine learning software platform,'' said Mimoun Cadosch Delmar, Founder & CEO of Matterworks.